Skip to main content
. 2019 Jun 13;44:607–617. doi: 10.1016/j.ebiom.2019.05.054

Table 1.

Patient demographics in the development and validation cohort.

Study 1 Study 2
Subjects (M/F) 26 (6/20) 12 (9/3)
Average Age [y] (SD) 44.1 (17.0) 56.7 (18.1)
Average Weight [kg] (SD) 80.7 (17.1) 84.6 (12.8)
Average Height [cm] (SD) 175.2 (7.5) 172.7 (6.5)
Average Glasgow Outcome Score [1](SD) 3.14 (1.39) N/A
Average Therapeutic Intensity Score [1](SD) 2.54 (1.07) 2.93 (0.75)
Number of deceased patients 5 N/A